- Location
1
result for "
B SMART technology
"-
LabCorp Uses B-Smart to Develop a New Laboratory-Based Antibiotic Susceptibility Assay
Dec 4, 2012Sequella has licensed its B-SMART technology to Laboratory Corporation of America (LabCorp) to allow LabCorp to develop a new laboratory-based antibiotic susceptibility assay for Mycobacterium tuberculosis and to use the assay in the US ...
Tags: LabCorp, B-SMART technology, Sequella
